{"id":"https://openalex.org/W4285028166","doi":"https://doi.org/10.1111/all.15433","title":"Non\u2010immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross\u2010reactivity with other iodinated contrast media","display_name":"Non\u2010immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross\u2010reactivity with other iodinated contrast media","publication_year":2022,"publication_date":"2022-07-11","ids":{"openalex":"https://openalex.org/W4285028166","doi":"https://doi.org/10.1111/all.15433","pmid":"https://pubmed.ncbi.nlm.nih.gov/35815908"},"language":"en","primary_location":{"id":"doi:10.1111/all.15433","doi":"https://doi.org/10.1111/all.15433","is_oa":false,"landing_page_url":"https://doi.org/10.1111/all.15433","pdf_url":null,"source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061292765","display_name":"Pedro M. Gamboa Seti\u00e9n","orcid":"https://orcid.org/0000-0002-7125-8709","observed_orcids":["https://orcid.org/0000-0002-7125-8709"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pedro Gamboa","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7125-8709","affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019638240","display_name":"Javier S\u00e1nchez de Vicente","orcid":"https://orcid.org/0000-0002-9397-460X","observed_orcids":["https://orcid.org/0000-0002-9397-460X"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier S\u00e1nchez de Vicente","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023664703","display_name":"Cristina Gal\u00e1n","orcid":"https://orcid.org/0000-0001-9733-7395","observed_orcids":["https://orcid.org/0000-0001-9733-7395"]},"institutions":[{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Gal\u00e1n","raw_affiliation_strings":["Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065987104","display_name":"Ignacio Jauregui","orcid":"https://orcid.org/0000-0001-9721-7246","observed_orcids":["https://orcid.org/0000-0001-9721-7246"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ignacio J\u00e1uregui","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017988020","display_name":"Aritza Segurola","orcid":"https://orcid.org/0000-0002-3919-0409","observed_orcids":["https://orcid.org/0000-0002-3919-0409"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Aritza Segurola","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052184067","display_name":"Eduardo Garc\u00eda\u2010Lirio","orcid":"https://orcid.org/0000-0001-5515-7396","observed_orcids":["https://orcid.org/0000-0001-5515-7396"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo Garc\u00eda\u2010Lirio","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085251977","display_name":"Yolanda Seras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Yolanda Seras","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042430726","display_name":"Ma. Dolores Mart\u00ednez\u2010Ant\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M\u00aa. Dolores Mart\u00ednez\u2010Ant\u00f3n","raw_affiliation_strings":["Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430"]},{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001204176","display_name":"A Arrien de Lecea","orcid":"https://orcid.org/0000-0003-0260-9162","observed_orcids":["https://orcid.org/0000-0003-0260-9162"]},"institutions":[{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Angel Arrien de Lecea","raw_affiliation_strings":["Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Alergia, Hospital Universitario Cruces, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061292765"],"corresponding_institution_ids":["https://openalex.org/I4210089430","https://openalex.org/I4210137412"],"apc_list":{"value":4900,"currency":"USD","value_usd":4900},"apc_paid":null,"fwci":1.1635,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.72870119,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"77","issue":"12","first_page":"3641","last_page":"3647"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iomeprol","display_name":"iomeprol","score":0.9769999980926514},{"id":"https://openalex.org/keywords/iodinated-contrast-media","display_name":"iodinated contrast media","score":0.9850000143051147},{"id":"https://openalex.org/keywords/skin-testing","display_name":"skin testing","score":0.8700000047683716},{"id":"https://openalex.org/keywords/iopamidol","display_name":"iopamidol","score":0.8859999775886536},{"id":"https://openalex.org/keywords/iopromide","display_name":"iopromide","score":0.875},{"id":"https://openalex.org/keywords/iobitridol","display_name":"iobitridol","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cross-reactivity","display_name":"cross-reactivity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/intravenous-challenge","display_name":"intravenous challenge","score":0.5},{"id":"https://openalex.org/keywords/contrast-media-tolerance","display_name":"contrast media tolerance","score":0.5619999766349792},{"id":"https://openalex.org/keywords/diagnostic-sensitivity-and-negative-predictive-value","display_name":"diagnostic sensitivity and negative predictive value","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C2776982972","wikidata":"https://www.wikidata.org/wiki/Q424788","display_name":"Iopamidol","level":3,"score":0.9741572141647339},{"id":"https://openalex.org/C2908522163","wikidata":"https://www.wikidata.org/wiki/Q3275337","display_name":"Iodinated contrast media","level":2,"score":0.7430671453475952},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6401495933532715},{"id":"https://openalex.org/C2779222893","wikidata":"https://www.wikidata.org/wiki/Q3275337","display_name":"Iodinated contrast","level":3,"score":0.6231592297554016},{"id":"https://openalex.org/C2778754328","wikidata":"https://www.wikidata.org/wiki/Q4202805","display_name":"Iopromide","level":3,"score":0.5671819448471069},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2552613615989685},{"id":"https://openalex.org/C2779786684","wikidata":"https://www.wikidata.org/wiki/Q906156","display_name":"Contrast medium","level":2,"score":0.25215935707092285},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.23103377223014832},{"id":"https://openalex.org/C544519230","wikidata":"https://www.wikidata.org/wiki/Q32566","display_name":"Computed tomography","level":2,"score":0.06453311443328857}],"mesh":[{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006969","descriptor_name":"Hypersensitivity, Immediate","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D006969","descriptor_name":"Hypersensitivity, Immediate","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D007472","descriptor_name":"Iohexol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007479","descriptor_name":"Iopamidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007479","descriptor_name":"Iopamidol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012882","descriptor_name":"Skin Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017613","descriptor_name":"Iodine Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/all.15433","doi":"https://doi.org/10.1111/all.15433","is_oa":false,"landing_page_url":"https://doi.org/10.1111/all.15433","pdf_url":null,"source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},{"id":"pmid:35815908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35815908","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1661967703","https://openalex.org/W1896664762","https://openalex.org/W1977586798","https://openalex.org/W1983335572","https://openalex.org/W1995941422","https://openalex.org/W2076327328","https://openalex.org/W2132936448","https://openalex.org/W2141186862","https://openalex.org/W2158471640","https://openalex.org/W2160160264","https://openalex.org/W2260770683","https://openalex.org/W2470632386","https://openalex.org/W2783596281","https://openalex.org/W2890349891","https://openalex.org/W2904518588","https://openalex.org/W2940162498","https://openalex.org/W2996739133","https://openalex.org/W3045186158","https://openalex.org/W3105124463"],"related_works":["https://openalex.org/W2761892929","https://openalex.org/W1995941422","https://openalex.org/W3118952399","https://openalex.org/W3165319391","https://openalex.org/W4408407338","https://openalex.org/W2141186862","https://openalex.org/W2031640693","https://openalex.org/W4382918267","https://openalex.org/W2239969546","https://openalex.org/W2185430169"],"abstract_inverted_index":{"BACKGROUND:":[0],"Iodinated":[1],"contrast":[2,60,97],"media":[3],"produce":[4],"non-immediate":[5],"hypersensitivity":[6],"reactions":[7],"(NIHR).":[8],"The":[9,203],"goal":[10],"of":[11,20,73,111,165,182,200],"this":[12],"prospective":[13],"study":[14],"was":[15,64,98,130,146,169,195],"to":[16,27,175],"determine":[17],"the":[18,24,58,79,119,166,178],"utility":[19],"skin":[21,67,76,153,161,167,183],"tests":[22,43,68,105,122,154,168,184],"and":[23,41,48,144,155,207],"subsequent":[25],"tolerance":[26,129],"negative":[28,95,125,160,179],"skin-tested":[29,96,126],"iodinated":[30,127],"contrasts":[31,192],"in":[32,52,62,100,108,132,149,157,185],"patients":[33,112,150,158,186],"with":[34,44,57,78,87,92,113,124,151,159,190],"NIHR":[35,114],"caused":[36],"by":[37,116],"iomeprol.":[38,117],"METHODS:":[39],"Prick":[40],"intradermal":[42],"iomeprol,":[45,176],"iopamidol,":[46],"iopromide,":[47],"iobitridol":[49],"were":[50,69,106],"performed":[51,99,123],"all":[53,101],"patients.":[54,102],"IV":[55,89],"challenge":[56,85,90,121],"causative":[59],"(iomeprol":[61],"90%)":[63],"made":[65],"if":[66],"negative.":[70],"In":[71],"case":[72],"a":[74,83],"positive":[75,84,107,152],"test":[77,86,91],"causal":[80],"contrast,":[81],"or":[82],"it,":[88],"an":[93],"alternative,":[94],"RESULTS:":[103],"Skin":[104],"47.6%":[109],"(20/42)":[110],"induced":[115],"Of":[118],"66":[120,201],"contrasts,":[128],"confirmed":[131],"35":[133],"(53%):":[134],"32":[135],"iomeron,":[136],"2":[137],"iobitridol,":[138],"1":[139],"iopamidol.":[140],"Cross-reactivity":[141],"between":[142,205],"iomeprol":[143,206],"iopamidol":[145,208],"22%":[147],"(4/20":[148],"5/21":[156],"tests).":[162],"CONCLUSIONS:":[163],"Sensitivity":[164],"less":[170],"than":[171],"50%":[172],"NIHRs":[173],"due":[174],"while":[177],"predictive":[180],"value":[181],"who":[187],"tolerated":[188,198],"challenges":[189],"alternative":[191],"(mainly":[193],"iopamidol)":[194],"53%":[196],"(35":[197],"out":[199],"performed).":[202],"cross-reactivity":[204],"is":[209],"high.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-07-12T00:00:00"}